Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 788

1.

A Synthesis of Elementary Mathematics Interventions: Comparisons of Students With Mathematics Difficulty With and Without Comorbid Reading Difficulty.

Powell SR, Doabler CT, Akinola OA, Therrien WJ, Maddox SA, Hess KE.

J Learn Disabil. 2019 Oct 21:22219419881646. doi: 10.1177/0022219419881646. [Epub ahead of print]

PMID:
31631747
2.

Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B.

J Thorac Oncol. 2019 Oct 9. pii: S1556-0864(19)33525-7. doi: 10.1016/j.jtho.2019.10.001. [Epub ahead of print]

PMID:
31605794
3.

Reasons Why Young Men Who Have Sex with Men Report Not Using HIV Pre-Exposure Prophylaxis: Perceptions of Burden, Need, and Safety.

Hess KM, Crawford J, Eanes A, Felner JK, Mittal ML, Smith LR, Hoenigl M, Amico KR.

AIDS Patient Care STDS. 2019 Oct;33(10):449-454. doi: 10.1089/apc.2019.0150.

PMID:
31584856
4.

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma.

Habra MA, Stephen B, Campbell M, Hess K, Tapia C, Xu M, Rodon Ahnert J, Jimenez C, Lee JE, Perrier ND, Boraddus RR, Pant S, Subbiah V, Hong DS, Zarifa A, Fu S, Karp DD, Meric-Bernstam F, Naing A.

J Immunother Cancer. 2019 Sep 18;7(1):253. doi: 10.1186/s40425-019-0722-x.

5.

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.

Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW.

JAMA Oncol. 2019 Sep 17. doi: 10.1001/jamaoncol.2019.2809. [Epub ahead of print]

PMID:
31529018
6.

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant.

Litton JK, Scoggins ME, Hess KR, Adrada BE, Murthy RK, Damodaran S, DeSnyder SM, Brewster AM, Barcenas CH, Valero V, Whitman GJ, Schwartz-Gomez J, Mittendorf EA, Thompson AM, Helgason T, Ibrahim N, Piwnica-Worms H, Moulder SL, Arun BK.

J Clin Oncol. 2019 Aug 28:JCO1901304. doi: 10.1200/JCO.19.01304. [Epub ahead of print]

PMID:
31461380
7.

Corrigendum to "Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials" [Lung Cancer 120 (June) (2018) 137-141].

Maymani H, Hess K, Groisberg R, Hong DS, Naing A, Piha-Paul S, Janku F, Fu S, Tsimberidou AM, Pant S, Karp D, Liu S, Sun M, Heymach J, Simon G, Meric-Bernstam F, Subbiah V.

Lung Cancer. 2019 Oct;136:158. doi: 10.1016/j.lungcan.2019.08.017. Epub 2019 Aug 21. No abstract available.

PMID:
31445783
8.

Improving HIV Surveillance Data by Using the ATra Black Box System to Assist Regional Deduplication Activities.

Ocampo JMF, Hamp A, Rhodes A, Smart JC, Pemmaraju R, Poschman K, Hess KL, Bhattacharjee R, Flynn C, Anderson BJ, Dowling JE, Maccormack F, Doshi R, Lum G, Maddox L, Moncur B, Barnhart JE, Maxwell J, Aurand SB, Hogan V, Wills D, Prowell S, Kassaye SG, Karn HE, Laffoon BT, Collmann J.

J Acquir Immune Defic Syndr. 2019 Sep 1;82 Suppl 1:S13-S19. doi: 10.1097/QAI.0000000000002090.

PMID:
31425390
9.

Topological exploration of artificial neuronal network dynamics.

Bardin JB, Spreemann G, Hess K.

Netw Neurosci. 2019 Jul 1;3(3):725-743. doi: 10.1162/netn_a_00080. eCollection 2019.

10.

Variation in Technical Quality of Breast MRI.

Ruiz-Flores L, Whitman GJ, Le-Petross HTC, Hess KR, Parikh JR.

Acad Radiol. 2019 Jul 29. pii: S1076-6332(19)30332-0. doi: 10.1016/j.acra.2019.07.002. [Epub ahead of print]

PMID:
31371208
11.

Optical Properties and Mechanical Modeling of Acetylated Transparent Wood Composite Laminates.

Foster KEO, Hess KM, Miyake GM, Srubar WV 3rd.

Materials (Basel). 2019 Jul 13;12(14). pii: E2256. doi: 10.3390/ma12142256.

12.

Applying Contemporary Management Principles to Implementing and Evaluating Value-Added Pharmacist Services.

Desselle SP, Moczygemba LR, Coe AB, Hess K, Zgarrick DP.

Pharmacy (Basel). 2019 Jul 20;7(3). pii: E99. doi: 10.3390/pharmacy7030099.

13.

Imaging Follow-up Versus Surgical Excision for Radial Scars Identified on Tomosynthesis-Guided Core Needle Biopsy.

Martaindale S, Omofoye TS, Teichgraeber DC, Hess KR, Whitman GJ.

Acad Radiol. 2019 Jul 13. pii: S1076-6332(19)30302-2. doi: 10.1016/j.acra.2019.05.012. [Epub ahead of print]

PMID:
31311772
14.

Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology?

Timme M, Thomas C, Spille DC, Stummer W, Ebel H, Ewelt C, Hans FJ, Schick U, Puchner M, Wildförster U, Bruns B, Trost HA, Holling M, Grauer O, Hess K, Brokinkel B.

Neurosurg Rev. 2019 Jun 3. doi: 10.1007/s10143-019-01125-0. [Epub ahead of print]

PMID:
31161444
15.

Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas.

Streckert EMS, Hess K, Sporns PB, Adeli A, Brokinkel C, Kriz J, Holling M, Eich HT, Paulus W, Spille DC, van Eck ATCJ, Raleigh DR, McDermott MW, Stummer W, Brokinkel B.

Acta Neurochir (Wien). 2019 Aug;161(8):1647-1656. doi: 10.1007/s00701-019-03956-8. Epub 2019 May 31.

PMID:
31147831
16.

Immediate pre-learning stress enhances baseline startle response and fear acquisition in a fear-potentiated startle paradigm.

Riggenbach MR, Weiser JN, Mosley BE, Hipskind JJ, Wireman LE, Hess KL, Duffy TJ, Handel JK, Kaschalk MG, Reneau KE, Rorabaugh BR, Norrholm SD, Jovanovic T, Zoladz PR.

Behav Brain Res. 2019 Oct 3;371:111980. doi: 10.1016/j.bbr.2019.111980. Epub 2019 May 27.

PMID:
31145979
17.

Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.

Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND.

Ann Surg Oncol. 2019 Oct;26(11):3593-3599. doi: 10.1245/s10434-019-07451-3. Epub 2019 May 20.

PMID:
31111352
18.

Not all patients with a diagnosis of a radial scar require excision.

Eghtedari M, Le-Petross H, Babiera GV, Albarracin CT, Hess KR, Woodtichartpreecha P, Whitman GJ.

Breast J. 2019 Jul;25(4):792-794. doi: 10.1111/tbj.13329. Epub 2019 May 13. No abstract available.

PMID:
31087426
19.

Prediction of high-grade histology and recurrence in meningiomas using routine preoperative magnetic resonance imaging - A systematic review.

Spille DC, Sporns PB, Heß K, Stummer W, Brokinkel B.

World Neurosurg. 2019 May 10. pii: S1878-8750(19)31291-4. doi: 10.1016/j.wneu.2019.05.017. [Epub ahead of print] Review.

PMID:
31082555
20.

The unfolding argument: Why IIT and other causal structure theories cannot explain consciousness.

Doerig A, Schurger A, Hess K, Herzog MH.

Conscious Cogn. 2019 Jul;72:49-59. doi: 10.1016/j.concog.2019.04.002. Epub 2019 May 9.

21.

Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy.

Teichgraeber DC, Martaindale S, Omofoye TS, Hess KR, Parikh JR, Whitman GJ.

Acad Radiol. 2019 May 7. pii: S1076-6332(19)30181-3. doi: 10.1016/j.acra.2019.03.022. [Epub ahead of print]

PMID:
31076332
22.

Remote ischemic preconditioning attenuates intestinal mucosal damage: insight from a rat model of ischemia-reperfusion injury.

Hummitzsch L, Zitta K, Berndt R, Wong YL, Rusch R, Hess K, Wedel T, Gruenewald M, Cremer J, Steinfath M, Albrecht M.

J Transl Med. 2019 Apr 29;17(1):136. doi: 10.1186/s12967-019-1885-4.

23.

Temperature-responsive biometamaterials for gastrointestinal applications.

Babaee S, Pajovic S, Kirtane AR, Shi J, Caffarel-Salvador E, Hess K, Collins JE, Tamang S, Wahane AV, Hayward AM, Mazdiyasni H, Langer R, Traverso G.

Sci Transl Med. 2019 Apr 17;11(488). pii: eaau8581. doi: 10.1126/scitranslmed.aau8581.

PMID:
30996082
24.

A search for cortical correlates of trait impulsivity in Parkinson´s disease.

Kubera KM, Schmitgen MM, Nagel S, Hess K, Herweh C, Hirjak D, Sambataro F, Wolf RC.

Behav Brain Res. 2019 Sep 2;369:111911. doi: 10.1016/j.bbr.2019.111911. Epub 2019 Apr 13.

PMID:
30991086
25.

Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).

Baez-Vallecillo L, Raghavendra AS, Hess KR, Barcenas CH, Moulder SL, Tripathy D, Valero V, Murthy RK.

Breast Cancer Res Treat. 2019 Jul;176(1):227-234. doi: 10.1007/s10549-018-05081-z. Epub 2019 Apr 11.

PMID:
30977027
26.

Beneficial Effect of Adjuvant Dabrafenib Plus Trametinib on Recurrence-Free Survival in Patients With Resected BRAFV600-Mutant Stage III Melanoma Seems to be Short-Lived.

Hess KR.

J Clin Oncol. 2019 May 20;37(15):1354-1355. doi: 10.1200/JCO.18.01768. Epub 2019 Apr 2. No abstract available.

PMID:
30939097
27.

Brownish and Indurated Plaques With Yellowish Papules: Challenge.

Duschner N, Hess K, Hendricks C, Schaller J.

Am J Dermatopathol. 2019 Mar 12. doi: 10.1097/DAD.0000000000001400. [Epub ahead of print] No abstract available.

PMID:
30908291
28.

Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.

George GC, Iwuanyanwu EC, Buford AS, Piha-Paul SA, Subbiah V, Fu S, Karp DD, Pant S, Hinojosa CO, Hess KR, Cleeland CS, Bernstam EV, Meric-Bernstam F, Hong DS.

J Med Internet Res. 2019 Mar 14;21(3):e10348. doi: 10.2196/10348.

29.

A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment.

Verma M, Vishwanath K, Eweje F, Roxhed N, Grant T, Castaneda M, Steiger C, Mazdiyasni H, Bensel T, Minahan D, Soares V, Salama JAF, Lopes A, Hess K, Cleveland C, Fulop DJ, Hayward A, Collins J, Tamang SM, Hua T, Ikeanyi C, Zeidman G, Mule E, Boominathan S, Popova E, Miller JB, Bellinger AM, Collins D, Leibowitz D, Batra S, Ahuja S, Bajiya M, Batra S, Sarin R, Agarwal U, Khaparde SD, Gupta NK, Gupta D, Bhatnagar AK, Chopra KK, Sharma N, Khanna A, Chowdhury J, Stoner R, Slocum AH, Cima MJ, Furin J, Langer R, Traverso G.

Sci Transl Med. 2019 Mar 13;11(483). pii: eaau6267. doi: 10.1126/scitranslmed.aau6267.

PMID:
30867322
30.

Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.

Fu C, Gombos DS, Lee J, George GC, Hess K, Whyte A, Hong DS.

Oncotarget. 2019 Jan 29;10(9):1011-1013. doi: 10.18632/oncotarget.26658. eCollection 2019 Jan 29.

31.

Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.

Viswanathan A, Vedantam A, Hess KR, Ochoa J, Dougherty PM, Reddy AS, Koyyalagunta D, Reddy S, Bruera E.

Oncologist. 2019 Jul;24(7):e590-e596. doi: 10.1634/theoncologist.2018-0570. Epub 2019 Feb 22.

PMID:
30796153
32.

Two-Tier Mapper, an unbiased topology-based clustering method for enhanced global gene expression analysis.

Jeitziner R, Carrière M, Rougemont J, Oudot S, Hess K, Brisken C.

Bioinformatics. 2019 Sep 15;35(18):3339-3347. doi: 10.1093/bioinformatics/btz052.

PMID:
30753284
33.

Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial.

Subbiah V, Anderson PM, Kairemo K, Hess K, Huh WW, Ravi V, Daw NC, Somaiah N, Ludwig JA, Benjamin RS, Chawla S, Hong DS, Meric-Bernstam F, Ravizzini G, Kleinerman E, Macapinlac H, Rohren E.

Clin Cancer Res. 2019 Jul 1;25(13):3802-3810. doi: 10.1158/1078-0432.CCR-18-3964. Epub 2019 Feb 7.

PMID:
30733229
34.

Objective Morphological Classification of Neocortical Pyramidal Cells.

Kanari L, Ramaswamy S, Shi Y, Morand S, Meystre J, Perin R, Abdellah M, Wang Y, Hess K, Markram H.

Cereb Cortex. 2019 Apr 1;29(4):1719-1735. doi: 10.1093/cercor/bhy339.

35.

Cancer-Related Internet Use and Online Social Networking Among Patients in an Early-Phase Clinical Trials Clinic at a Comprehensive Cancer Center.

George GC, Buford A, Hess K, Piha-Paul SA, Zinner R, Subbiah V, Hinojosa C, Cleeland CS, Meric-Bernstam F, Bernstam EV, Hong DS.

JCO Clin Cancer Inform. 2018 Dec;2:1-14. doi: 10.1200/CCI.17.00030.

36.

Correction to: Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapy.

Beechar VB, Prabhu SS, Bastos D, Weinberg JS, Stafford RJ, Fuentes D, Hess KR, Rao G.

J Neurooncol. 2019 Jan;141(2):475. doi: 10.1007/s11060-019-03093-3.

PMID:
30635762
37.

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.

Yam C, Esteva FJ, Patel MM, Raghavendra AS, Ueno NT, Moulder SL, Hess KR, Shroff GS, Hodge S, Koenig KH, Chavez Mac Gregor M, Griner RL, Yeung SJ, Hortobagyi GN, Valero V.

Invest New Drugs. 2019 Apr;37(2):345-351. doi: 10.1007/s10637-018-0700-z. Epub 2019 Jan 5.

PMID:
30610588
38.

Pharmacy-Based Travel Health Services in the United States.

Hurley-Kim K, Goad J, Seed S, Hess KM.

Pharmacy (Basel). 2018 Dec 27;7(1). pii: E5. doi: 10.3390/pharmacy7010005. Review.

39.

Estimating national rates of HIV infection among MSM, persons who inject drugs, and heterosexuals in the United States.

Crepaz N, Hess KL, Purcell DW, Hall HI.

AIDS. 2019 Mar 15;33(4):701-708. doi: 10.1097/QAD.0000000000002111.

PMID:
30585840
40.

Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging.

Adeli A, Hess K, Mawrin C, Streckert EMS, Stummer W, Paulus W, Kemmling A, Holling M, Heindel W, Schmidt R, Spille DC, Sporns PB, Brokinkel B.

Oncotarget. 2018 Nov 13;9(89):35974-35982. doi: 10.18632/oncotarget.26313. eCollection 2018 Nov 13.

41.

Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients.

Grauer O, Jaber M, Hess K, Weckesser M, Schwindt W, Maring S, Wölfer J, Stummer W.

J Neurooncol. 2019 Jan;141(1):83-94. doi: 10.1007/s11060-018-03005-x. Epub 2018 Dec 1.

42.

Moving Precision Oncology Forward Amid Myths and Misconceptions.

Janku F, Hess KR, Yap TA.

JAMA Oncol. 2018 Dec 1;4(12):1788-1789. doi: 10.1001/jamaoncol.2018.5064. No abstract available.

PMID:
30419079
43.

Combined effusive-explosive silicic volcanism straddles the multiphase viscous-to-brittle transition.

Wadsworth FB, Witcher T, Vossen CEJ, Hess KU, Unwin HE, Scheu B, Castro JM, Dingwell DB.

Nat Commun. 2018 Nov 8;9(1):4696. doi: 10.1038/s41467-018-07187-w.

44.

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, de Groot JF, Alfred Yung WK, Penas-Prado M.

Cancer. 2019 Feb 1;125(3):424-433. doi: 10.1002/cncr.31811. Epub 2018 Oct 25. Erratum in: Cancer. 2019 Apr 15;125(8):1387.

PMID:
30359477
45.

Report of the 2017-2018 Strategic Engagement Standing Committee.

Moore GD, Arya V, Chahine EB, Ginsburg DB, Hess KM, Moye PM, Nelson P, Ekoma JO.

Am J Pharm Educ. 2018 Sep;82(7):7148. doi: 10.5688/ajpe7148.

46.

HDAC1 overexpression enhances β-cell proliferation by down-regulating Cdkn1b/p27.

Draney C, Austin MC, Leifer AH, Smith CJ, Kener KB, Aitken TJ, Hess KH, Haines AC, Lett LA, Hernandez-Carretero A, Fueger PT, Arlotto M, Tessem JS.

Biochem J. 2018 Dec 19;475(24):3997-4010. doi: 10.1042/BCJ20180465.

PMID:
30322885
47.

Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials.

Sen S, Carmagnani Pestana R, Hess K, Viola GM, Subbiah V.

Ann Oncol. 2018 Dec 1;29(12):2396-2398. doi: 10.1093/annonc/mdy453. No abstract available.

PMID:
30307530
48.

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer.

Wang Y, Wang Z, Piha-Paul S, Janku F, Subbiah V, Shi N, Hess K, Broaddus R, Shan B, Naing A, Hong D, Tsimberidou AM, Karp D, Lu C, Papadimitrakopoulou V, Heymach J, Meric-Bernstam F, Fu S.

Oncotarget. 2018 Sep 7;9(70):33258-33270. doi: 10.18632/oncotarget.25947. eCollection 2018 Sep 7.

49.

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic.

Dembla V, Somaiah N, Barata P, Hess K, Fu S, Janku F, Karp DD, Naing A, Piha-Paul SA, Subbiah V, Tsimberidou AM, Shaw K, Meric-Bernstam F, Hong DS.

Oncotarget. 2018 Sep 4;9(69):33232-33243. doi: 10.18632/oncotarget.26075. eCollection 2018 Sep 4.

50.

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.

Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JPW, Bui TN, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, Meric-Bernstam F, Hunt KK, Keyomarsi K.

Clin Cancer Res. 2018 Dec 15;24(24):6594-6610. doi: 10.1158/1078-0432.CCR-18-1446. Epub 2018 Sep 4.

PMID:
30181387

Supplemental Content

Support Center